Wetzler, M., Andrews, C., Ford, L. A., Tighe, S., Barcos, M., Sait, S. N., . . . Baumann, H. (2011). Phase I Study of Arsenic Trioxide, High-Dose Cytarabine and Idarubicin to Down-Regulate Constitutive STAT3 Activity in <60 Year Old Acute Myeloid Leukemia Patients.
Citação norma ChicagoWetzler, Meir, et al. Phase I Study of Arsenic Trioxide, High-Dose Cytarabine and Idarubicin to Down-Regulate Constitutive STAT3 Activity in <60 Year Old Acute Myeloid Leukemia Patients. 2011.
Deismireacht MLAWetzler, Meir, et al. Phase I Study of Arsenic Trioxide, High-Dose Cytarabine and Idarubicin to Down-Regulate Constitutive STAT3 Activity in <60 Year Old Acute Myeloid Leukemia Patients. 2011.
Rabhadh: D'fhéadfadh nach mbeadh na deismireachtaí seo 100% cruinn i gcónaí.